Related Experiment Video
Updated: Aug 9, 2025
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Advances in NK cell therapy for brain tumors
Jawad Fares1,2, Zachary B Davis3, Julian S Rechberger4,5
1Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.
Abstract:
Despite advances in treatment regimens that comprise surgery, chemotherapy, and radiation, outcome of many brain tumors remains dismal, more so when they recur. The proximity of brain tumors to delicate neural structures often precludes complete surgical resection. Toxicity and long-term side effects of systemic therapy remain a concern. Novel therapies are warranted. The field of NK cell-based cancer therapy has grown exponentially and currently constitutes a major area of immunotherapy innovation. This provides a new avenue for the treatment of cancerous lesions in the brain. In this review, we explore the mechanisms by which the brain tumor microenvironment suppresses NK cell mediated tumor control, and the methods being used to create NK cell products that subvert immune suppression. We discuss the pre-clinical studies evaluating NK cell-based immunotherapies that target several neuro-malignancies and highlight advances in molecular imaging of NK cells that allow monitoring of NK cell-based therapeutics. We review current and ongoing NK cell based clinical trials in neuro-oncology.
Insights
Novel immunotherapies using Natural Killer (NK) cells show promise for treating brain tumors, overcoming limitations of current treatments and addressing immune suppression within the tumor microenvironment.
Area of Science:
- Neuro-oncology
- Immunotherapy
- Cellular Therapy
Background:
- Current brain tumor treatments (surgery, chemotherapy, radiation) have limited efficacy, especially for recurrent tumors.
- Tumor proximity to neural structures restricts surgical options, and systemic therapies cause significant toxicity.
- There is a critical need for novel therapeutic strategies for brain malignancies.
Purpose of the Study:
- To review the potential of Natural Killer (NK) cell-based immunotherapy for neuro-oncology.
- To explore mechanisms of immune suppression in the brain tumor microenvironment affecting NK cells.
- To highlight strategies for developing NK cell therapies and advances in their monitoring.
Main Methods:
- Review of pre-clinical studies on NK cell-based immunotherapies for neuro-malignancies.
- Analysis of methods to engineer NK cells to overcome immune suppression.
- Examination of molecular imaging techniques for tracking NK cell therapeutics.
- Survey of current and ongoing clinical trials in NK cell-based neuro-oncology.
Main Results:
- The brain tumor microenvironment actively suppresses NK cell activity.
- Methods are being developed to enhance NK cell function against brain tumors.
- Molecular imaging allows for in vivo monitoring of NK cell therapeutics.
- Several pre-clinical and clinical investigations are underway.
Conclusions:
- NK cell-based immunotherapy represents a promising new frontier for brain tumor treatment.
- Overcoming immune suppression in the tumor microenvironment is key to successful NK cell therapy.
- Advances in NK cell engineering and imaging support clinical translation for neuro-oncology.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:27Tumor Immunotherapy
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists